本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Rhythm Pharmaceuticals Inc.

113.35
+1.911.71%
成交量:35.25萬
成交額:3,983.77萬
市值:78.04億
市盈率:-36.36
高:114.07
開:112.73
低:111.79
收:111.44
52周最高:122.20
52周最低:74.50
股本:6,885.21萬
流通股本:6,539.41萬
量比:0.68
換手率:0.54%
股息:- -
股息率:- -
每股收益(TTM):-3.1172
每股收益(LYR):-3.1100
淨資產收益率:-117.04%
總資產收益率:-30.96%
市淨率:75.78
市盈率(LYR):-36.45

資料載入中...

2025/05/30

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/05/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/05/07

重要事件披露

Form 8-K - Current report
2025/04/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/04/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/04/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/04/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/04/07

重要事件披露

Form 8-K - Current report
2025/03/20

重要事件披露

Form 8-K - Current report
2025/03/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/28

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/02/28

重要事件披露

Form 8-K - Current report
2025/02/28

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/02/26

重要事件披露

Form 8-K - Current report
2025/02/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/10

重要事件披露

Form 8-K - Current report
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]